The Billion-Dollar Molecule
 | This article needs additional citations for verification. (November 2013) |
 Paperback edition | |
| Author | Barry Werth |
|---|---|
| Language | English |
| Subject | Biotechnology |
| Genre | Non-fiction |
| Publisher | Simon & Schuster |
Publication date | February 16, 1994 |
| Publication place | United States |
| Pages | 448 pp. (hardcover) |
| ISBN | 0-671-51057-6 |
The Billion-Dollar Molecule is a book[1] by journalist Barry Werth about the founding and early research efforts of the American biotechnology company Vertex Pharmaceuticals, which was founded in 1989 by Joshua Boger and was among the first biotechnology companies to adopt an explicit strategy of rational drug design as opposed to techniques based on combinatorial chemistry.
This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design. This book is a mixture of finance and technology.
In February, 2014, Barry Werth published a follow-on book, The Antidote,[2] that looks at Vertex 20 years later after his original effort.[3]
References
[edit]- ^ Barry Werth (February 16, 1994), The Billion-Dollar Molecule: The Quest for the Perfect Drug, Simon & Schuster, pp. 448, ISBN 0671510576
- ^ Barry Werth (December 2014). The Antidote Inside the World of New Pharma. Simon & Schuster. p. 448. ISBN 9781451655674. Retrieved July 19, 2015.
- ^ "Barry Werth". barrywerth.com. Archived from the original on May 15, 2013. Retrieved 6 May 2023.
 Pharmaceutical industry in the United States | |
|---|---|
| Companies | |
| Regulatory bodies | |
| Professional bodies | |
| Miscellaneous | |
| Books |
|
| Lists | |
| Related templates | |
| Related categories |
|
 | This article about a book on a company or brand is a stub. You can help Wikipedia by expanding it. |
 | This article about a chemistry-related book is a stub. You can help Wikipedia by expanding it. |